For example, Kitange et al. reported that RBBP4 knockdown in glioblastoma enhanced sensitivity to temozolomide by suppressing the expression of MGMT, RAD51, and FIGNL1 genes.26 This evidence concerns the gene RBBP4 and glioblastoma.